Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
2
29%
Ph not_applicable
5
71%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Other(1)

Detailed Status

Completed3
Active, not recruiting2
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (28.6%)
N/A5 (71.4%)

Trials by Status

active_not_recruiting229%
unknown114%
enrolling_by_invitation114%
completed343%

Recent Activity

2 active trials
Showing 5 of 7
active_not_recruitingphase_1

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG

NCT05615623
active_not_recruitingphase_1

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

NCT05630209
completednot_applicable

Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor

NCT03465761
enrolling_by_invitationnot_applicable

A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor

NCT06676501
unknownnot_applicable

Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor

NCT03935581
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05615623Phase 1

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG

Active Not Recruiting
NCT05630209Phase 1

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Active Not Recruiting
NCT03465761Not Applicable

Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor

Completed
NCT06676501Not Applicable

A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor

Enrolling By Invitation
NCT03935581Not Applicable

Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor

Unknown
NCT01142791Not Applicable

Safety Study of ExAblate for the Treatment of Uterine Fibroids

Completed
NCT02348411Not Applicable

A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-Refractory MDD

Completed

All 7 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
7